According to FutureWise analysis the market for Anti-Asthma TDM Assay Kits in 2023 is US$ 19.12 billion, and is expected to reach US$ 30.98 billion by 2031 at a CAGR of 6.22% over the forecast period of 2023-2031.
Anti-asthma TDM assay kits are tools designed to monitor the drug intensity in the serum and plasma user for asthma. These kits are ready-to-use liquids that are the perfect alternative for the technologies that are used for therapeutic drug monitoring. Therapeutic drug monitoring measures specific drugs and their breakdown metabolites at timed intervals to maintain a stable concentration of the medication in the blood. Some of the monitored medications tend to have a limited "therapeutic index," which is a ratio between the toxic and effective doses of medication. As soon as a drug enters the body, various processes start eliminating the drug from the body. The time required for the body to reduce the drug concentration to half from its initial level is called the half-life of the drug. It generally takes around five half-lives to eradicate a drug from the body.
Many drugs that require therapeutic monitoring are consumed over an individual's lifetime. They must be maintained at stable concentrations year after year while the individual ages and goes through life events that may change that individual's therapeutic level, including pregnancies, infections, temporary illnesses, surgeries, emotional and physical stresses, and accidents. Over time, individuals may also acquire other chronic conditions that require lifetime medication and may affect the processing of their monitored drugs. These conditions include cardiovascular disease, thyroid disease, liver disease, kidney disease, and HIV.
FutureWise Market Research has published a report that provides an insightful analysis anti-asthma TDM assay kits market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anti-asthma TDM assay kits market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.